Jessica Richman’s daughter Cayden died of influenza at age 3. Flu vaccination may have saved her other daughter’s life.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
The gap between the diseases we fear and the actual dangers we face is significant. This Halloween, CIDRAP Director Michael Osterholm outlines the public health threats that worry him most.
Measured by how many Americans it kills each year—an estimated 24,000 last season—flu deserves much more attention than it gets.
Adjuvanted and high-dose flu vaccines show similar efficacy in preventing infection and hospitalization in US adults aged 65 and older.
Some people might shed the most influenza virus RNA just as their symptoms start to improve and they return to ordinary life.
Pneumonia also contributes to excess death, along with malnutrition, pneumonitis, non-vehicle accidents, and drowning.
Also, the FDA appointed 4 men to senior leadership roles, including the newly created position of deputy commissioner for technology and AI.
A new study highlights the factors that keep vaccine-willing adults from getting immunized.
Symptoms that persist for three months or more are also common after other respiratory viral infections like the flu and RSV.
Experts say people who want the vaccines will be able to access them, and insurance will cover them.
The real-world study linked the antiviral to a 31% lower risk of needing intensive care, regardless of time to treatment.
